These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 36583471)

  • 1. Weekly symptom profiles of nonhospitalized individuals infected with SARS-CoV-2 during the Omicron outbreak in Hong Kong: A retrospective observational study from a telemedicine center.
    Luo J; Zhang J; Tang HT; Wong HK; Ma Y; Xie D; Peng B; Lyu A; Cheung CH; Bian Z
    J Med Virol; 2023 Feb; 95(2):e28447. PubMed ID: 36583471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral kinetics of SARS-CoV-2 following onset of COVID-19 in symptomatic patients infected with the ancestral strain and omicron BA.2 in Hong Kong: a retrospective observational study.
    Lin Y; Wu P; Tsang TK; Wong JY; Lau EHY; Yang B; Leung GM; Cowling BJ
    Lancet Microbe; 2023 Sep; 4(9):e722-e731. PubMed ID: 37659420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of COVID-19 symptoms with omicron subvariants BA.2 and BA.5, host status, and clinical outcomes in Japan: a registry-based observational study.
    Nakakubo S; Kishida N; Okuda K; Kamada K; Iwama M; Suzuki M; Yokota I; Ito YM; Nasuhara Y; Boucher RC; Konno S
    Lancet Infect Dis; 2023 Nov; 23(11):1244-1256. PubMed ID: 37399831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and risk factors of long COVID 6-12 months after infection with the Omicron variant among nonhospitalized patients in Hong Kong.
    Luo J; Zhang J; Tang HT; Wong HK; Lyu A; Cheung CH; Bian Z
    J Med Virol; 2023 Jun; 95(6):e28862. PubMed ID: 37334978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profiles of Cough and Associated Risk Factors in Nonhospitalized Individuals With SARS-CoV-2 Omicron Variant Infection: Cross-Sectional Online Survey in China.
    Xu T; Chen Y; Zhan W; Chung KF; Qiu Z; Huang K; Chen R; Xie J; Wang G; Zhang M; Wang X; Yao H; Liao X; Zhang Y; Zhang G; Zhang W; Sun D; Zhu J; Jiang S; Feng J; Zhao J; Sun G; Huang H; Zhang J; Wang L; Wu F; Li S; Xu P; Chi C; Chen P; Jiang M; He W; Huang L; Luo W; Li S; Zhong N; Lai K;
    JMIR Public Health Surveill; 2024 Feb; 10():e47453. PubMed ID: 38315527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Characteristics of SARS-CoV-2 Omicron infection in children imported from Hong Kong].
    Ma WJ; Wang XS; Tian H; Zhu YF; Wei ZQ; Xu J; Zhu QR; Zeng M
    Zhonghua Er Ke Za Zhi; 2022 Jun; 60(6):539-544. PubMed ID: 35658359
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative analysis of symptom profile and risk of death associated with infection by SARS-CoV-2 and its variants in Hong Kong.
    Kwok KO; Wei WI; Mcneil EB; Tang A; Tang JW; Wong SYS; Yeoh EK
    J Med Virol; 2024 Feb; 96(2):e29326. PubMed ID: 38345166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and severity of SARS-CoV-2 reinfection, a multicenter cohort study in Shanghai, China.
    Yu W; Guo Y; Hu T; Liu Y; Fan Q; Guo L; Zheng B; Kong Y; Zhu H; Yu J; Chen S; Zhang Y; Wang J; Li F; Yang F; Wang Y; Zhu Y; Huang Y; Shen Z; Ruan Y; Mao R; Zhang J
    J Med Virol; 2023 Aug; 95(8):e28997. PubMed ID: 37537950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19-Related Symptoms during the SARS-CoV-2 Omicron (B.1.1.529) Variant Surge in Japan.
    Akaishi T; Kushimoto S; Katori Y; Sugawara N; Egusa H; Igarashi K; Fujita M; Kure S; Takayama S; Abe M; Kikuchi A; Ohsawa M; Ishizawa K; Abe Y; Imai H; Inaba Y; Iwamatsu-Kobayashi Y; Nishioka T; Onodera K; Ishii T
    Tohoku J Exp Med; 2022 Sep; 258(2):103-110. PubMed ID: 36002251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of Infections with SARS-CoV-2 Omicron BA.2 Variant, Hong Kong, January-March 2022.
    Mefsin YM; Chen D; Bond HS; Lin Y; Cheung JK; Wong JY; Ali ST; Lau EHY; Wu P; Leung GM; Cowling BJ
    Emerg Infect Dis; 2022 Sep; 28(9):1856-1858. PubMed ID: 35914518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and upper airway characteristics of 3715 patients with the Omicron variant of SARS-Cov-2 in Changchun, China.
    Sha J; Meng C; Sun J; Sun L; Gu R; Liu J; Zhu X; Zhu D
    J Infect Public Health; 2023 Mar; 16(3):422-429. PubMed ID: 36731245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical symptom profile of hospitalized COVID-19 Brazilian patients according to SARS-CoV-2 variants.
    Hojo-Souza NS; Freitas VLS; Guidoni DL; Souza FSH
    Epidemiol Health; 2023; 45():e2023079. PubMed ID: 37654165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics and analysis of risk factors for disease progression of patients with SARS-CoV-2 Omicron variant infection: A retrospective study of 25207 cases in a Fangcang hospital.
    Ying-Hao P; Yuan-Yuan G; Hai-Dong Z; Qiu-Hua C; Xue-Ran G; Hai-Qi Z; Hua J
    Front Cell Infect Microbiol; 2022; 12():1009894. PubMed ID: 36389157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative symptomatology of infection with SARS-CoV-2 variants Omicron (B.1.1.529) and Delta (B.1.617.2) from routine contact tracing data in England.
    Ekroth AKE; Patrzylas P; Turner C; Hughes GJ; Anderson C
    Epidemiol Infect; 2022 Aug; 150():e162. PubMed ID: 35975466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 Infection With the Omicron SARS-CoV-2 Variant in a Cohort of Kidney and Kidney Pancreas Transplant Recipients: Clinical Features, Risk Factors, and Outcomes.
    Wong G; Rowlandson M; Sabanayagam D; Ginn AN; Kable K; Sciberras F; Au E; Draper J; Arnott A; Sintchenko V; Dwyer DE; Chen SCA; Kok J
    Transplantation; 2022 Sep; 106(9):1860-1866. PubMed ID: 35675438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of Vaccine Effectiveness of CoronaVac and BNT162b2 Against Severe Outcomes Over Time Among Patients With SARS-CoV-2 Omicron.
    Wei Y; Jia KM; Zhao S; Hung CT; Mok CKP; Poon PKM; Man Leung EY; Wang MH; Yam CHK; Chow TY; Guo Z; Yeoh EK; Chong KC
    JAMA Netw Open; 2023 Feb; 6(2):e2254777. PubMed ID: 36735253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.
    Accorsi EK; Britton A; Fleming-Dutra KE; Smith ZR; Shang N; Derado G; Miller J; Schrag SJ; Verani JR
    JAMA; 2022 Feb; 327(7):639-651. PubMed ID: 35060999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating the serial intervals of SARS-CoV-2 Omicron BA.4, BA.5, and BA.2.12.1 variants in Hong Kong.
    Guo Z; Zhao S; Yam CHK; Li C; Jiang X; Chow TY; Chong KC; Yeoh EK
    Influenza Other Respir Viruses; 2023 Feb; 17(2):e13105. PubMed ID: 36824395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk and symptoms of COVID-19 in health professionals according to baseline immune status and booster vaccination during the Delta and Omicron waves in Switzerland-A multicentre cohort study.
    Babouee Flury B; Güsewell S; Egger T; Leal O; Brucher A; Lemmenmeier E; Meier Kleeb D; Möller JC; Rieder P; Rütti M; Schmid HR; Stocker R; Vuichard-Gysin D; Wiggli B; Besold U; McGeer A; Risch L; Friedl A; Schlegel M; Kuster SP; Kahlert CR; Kohler P;
    PLoS Med; 2022 Nov; 19(11):e1004125. PubMed ID: 36342956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.